health canada | InvestmentPitch

Videos Tagged: health canada

Canntab receives Cannabis Standard Processing & Sales for Medical Purposes Licence from Health Canada	Canntab Therapeutics has been granted a Cannabis Research Licence by Health Canada	Voyageur Pharma confirms Frances Creek Barite meets all Pharmaceutical Grade Specifications
New Listing: Adastra Labs Holdings (CSE:XTRX)	Nextleaf Solutions licenses IP to Cannabis Processing Equipment Distribution Company	GTEC launches new ultra-premium recreational cannabis brands in BC and Saskatchewan
THC BioMed exceeds $1 million in revenues in the first quarter of the current fiscal year	Feature Company: Hill Street Beverage Company (TSXV:BEER)	THC BioMed submitted a new product application to Health Canada for THC BioMed's Pure Cannabis Sticks
Nextleaf Solutions, a cannabis extraction and processing technology company, acquiring a U.S. patent pending hydrocarbon extraction process and award-winning formulation for popular cannabis concentrate known as “shatter”	New Listing: Pasha Brands (CSE:CRFT)	Canntab signs term sheet with Heritage Cannabis to process hemp into high quality CBD oil for Canntab's gelcaps
Geyser Brands signed a definitive agreement to acquire Solace Management Group	Canntab receives cultivation licence for industrial hemp, secures 2 Canadian properties totaling 560 acres	Benchmark Botanics signs letter of intent with China-based Zejiang Yatai Pharmaceutical to advance CBD products
New Listing: CanadaBis Capital (TSXV:CANB)	Canntab Approaches Revenue with FSD Pharma's New "Sale for Medical Purposes" Cannabis License	New Listing: Cansortium Inc. (CSE:TIUM.U)
Lotus Ventures obtains “Standard Cultivation” & “Sale for Medical Purposes” cannabis licences from Health Canada	Valeo Pharma Inc. (CSE:VPH) New Listing	Eve & Co's Pre-Rolls now Available in Newfoundland & Labrador Licensed Cannabis Retails and Government's Cannabis Website
Yield Growth is launching three hemp-based skin care products next week under the Urban Juve brand	Terranueva Corporation (CSE:TEQ) New Listing	FSD Pharma’s cannabis facility in Ontario officially valuated at $105 million, forecast to hit $420 million after completion of 3 million Sq Ft expansion
FSD Pharma Inc. has appointed Rupert Haynes as Chief Executive Officer	LiveWell Canada Inc. (CSE:LVWL) New Listing	MJardin Group (CSE:MJAR) New Listing
FSD Pharma, a licensed cannabis producer, adds high level government relations executive, David Urban to Board of Directors	Canntab Therapetics files application to become Licensed Producer under ACMPR	THC BioMed (CSE:THC) delivered its first shipment of cannabis to the province of British Columbia